{"id":9212,"name":"BioGenerator Ventures","slug":"biogenerator-ventures","website":"https://www.biogenerator.com","hqGeo":"St. Louis, Missouri","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Healthcare","SaaS"],"excludedSectors":[],"checkSizeMin":100000,"checkSizeMax":1000000,"thesisSummary":"Midwest regional specialist backing bioscience startups from formation through seed, with strong ties to translational science, life sciences tools, and early company building. Often invests in science-first companies before larger coastal firms engage.","thesisNarrative":null,"logoUrl":null,"aumUsd":null,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"Confluence Life Sciences","companyUrl":null,"stage":null,"sector":"Biotech","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Peptyde Bio","companyUrl":null,"stage":null,"sector":"Biotech","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"CoverCress","companyUrl":null,"stage":"Seed/Series A","sector":"Agtech","investmentYear":null,"description":"Develops high-yield cover crops from mustard plants for sustainable agriculture.","amountUsd":null,"relevanceNote":null,"fundName":"BioGenerator Fund I"},{"companyName":"Benson Hill","companyUrl":null,"stage":"Series A","sector":"Agtech","investmentYear":null,"description":"Uses AI and genomics for crop improvement and sustainable food ingredients.","amountUsd":null,"relevanceNote":null,"fundName":"BioGenerator Fund I"},{"companyName":"Canopy Biosciences","companyUrl":null,"stage":"Series A","sector":"Research tools","investmentYear":null,"description":"Provides spatial biology tools for research and drug discovery.","amountUsd":null,"relevanceNote":null,"fundName":"BioGenerator Fund I"},{"companyName":"Galera Therapeutics","companyUrl":null,"stage":"Series B","sector":"Therapeutics","investmentYear":null,"description":"Develops superoxide dismutase mimetics to protect healthy tissue during radiation therapy.","amountUsd":null,"relevanceNote":null,"fundName":"BioGenerator Fund I"},{"companyName":"MediBeacon","companyUrl":null,"stage":"Series A","sector":"Diagnostics","investmentYear":null,"description":"Develops fluorescent imaging agents for kidney function diagnostics.","amountUsd":null,"relevanceNote":null,"fundName":"BioGenerator Fund I"},{"companyName":"Arch Oncology","companyUrl":null,"stage":"Series A","sector":"Therapeutics","investmentYear":null,"description":"Engineers antibodies targeting KIF18A for cancer treatment.","amountUsd":null,"relevanceNote":null,"fundName":"BioGenerator Fund I"},{"companyName":"Cardialen","companyUrl":null,"stage":"Seed/Series A","sector":"Medical devices","investmentYear":null,"description":"Develops low-energy defibrillation therapy for cardiac arrhythmias.","amountUsd":null,"relevanceNote":null,"fundName":"BioGenerator Fund I"},{"companyName":"SentiAR","companyUrl":null,"stage":"Seed","sector":"Medical devices","investmentYear":null,"description":"Builds AI-enabled image-guided therapy systems for cardiac interventions.","amountUsd":null,"relevanceNote":null,"fundName":"BioGenerator Fund I"},{"companyName":"Geneoscopy","companyUrl":null,"stage":"Early-stage","sector":"Diagnostics","investmentYear":null,"description":"Develops non-invasive colorectal cancer diagnostics via stool RNA testing.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Wugen","companyUrl":null,"stage":null,"sector":"Biotech","investmentYear":null,"description":"Engineers natural killer (NK) cell therapies for cancer.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Omniose","companyUrl":null,"stage":"Pre-seed/seed","sector":"Therapeutics","investmentYear":null,"description":"Develops scalable enzymatic synthesis of complex carbohydrates for therapeutics.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Plastomics","companyUrl":null,"stage":"Seed","sector":"Agtech","investmentYear":null,"description":"Creates plastid-transformed plants for high-yield biologics and traits.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Lymbus Oncology","companyUrl":null,"stage":"Seed","sector":"Therapeutics","investmentYear":null,"description":"Develops antibody-drug conjugates for solid tumor cancers.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Cadre Bioscience","companyUrl":null,"stage":"Seed","sector":"Research tools","investmentYear":null,"description":"Provides AI-driven drug discovery platform for protein targets.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Edison Agrosciences","companyUrl":null,"stage":"Seed","sector":"Agtech","investmentYear":null,"description":"Engineers crops for improved photosynthesis and yield.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Pairidex","companyUrl":null,"stage":"Series Seed","sector":"biotech / diagnostics","investmentYear":null,"description":"Develops a highly sensitive RNA-based MRD assay for leukemia and other fusion-driven hematologic malignancies","amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":2,"partners":[{"id":21832,"name":"Sach Chitnis","title":"General Partner, Jump Capital","seniority":null,"focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":21831,"name":"Donn Rubin","title":"Founder","seniority":null,"focusTags":["Biotech","Life Sciences","Regional Innovation"],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[],"activity":{"lastInvestmentYear":null,"investmentsThisYear":0},"activityItems":[{"kind":"news","title":"BioGenerator Startup Connect unites life sciences entrepreneurs with investors","url":"https://www.biogeneratorventures.com/news-media/biogenerator-startup-connect-unites-life-sciences-entrepreneurs-with-investors","source":"BioGenerator","occurredAt":"2026-10-13T00:00:00.000Z"},{"kind":"news","title":"BioGenerator plans to 'quadruple down' on St. Louis biotech startups","url":"https://www.biogeneratorventures.com/news-media/biogenerator-plans-to-quadruple-down-on-st-louis-biotech-startups","source":"BioGenerator","occurredAt":"2026-10-13T00:00:00.000Z"},{"kind":"news","title":"Celebrating the BioGenerator Ventures Portfolio","url":"https://www.biogeneratorventures.com/news-media/celebrating-the-biogenerator-ventures-portfolio","source":"BioGenerator","occurredAt":"2026-10-10T00:00:00.000Z"}],"contentUpdatedAt":"2026-10-27T02:43:36.764Z","investorType":"vc","preferredApproach":"cold outreach ok","prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":11767,"name":"LiftScale Partners","slug":"liftscale-partners","logoUrl":null,"website":"https://weareliftscale.com/","stageFocus":["Pre-Seed"],"sectorTags":["AI / ML","SaaS"],"hqGeo":"San Francisco, CA"},{"id":11323,"name":"Mountain Pine Capital","slug":"mountain-pine-capital","logoUrl":null,"website":"https://mountainpineholdings.com/","stageFocus":["Seed"],"sectorTags":["Consumer","Healthcare","Real Estate"],"hqGeo":"Salt Lake City, UT"},{"id":3892,"name":"Madrona Pioneer Fund","slug":"madrona-pioneer-fund","logoUrl":null,"website":"https://www.madrona.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Real Estate","SaaS","Enterprise","Security","Developer Tools"],"hqGeo":"Seattle, WA"},{"id":1621,"name":"Canary","slug":"canary","logoUrl":null,"website":"https://www.canary.capital/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Fintech","AI / ML","SaaS","Healthcare","Enterprise"],"hqGeo":"São Paulo, Brazil"},{"id":12955,"name":"Jovono","slug":"jovono","logoUrl":null,"website":"https://jovono.com","stageFocus":["Seed","Series A"],"sectorTags":["Climate / Energy","Fintech","Consumer","SaaS","Healthcare"],"hqGeo":"Los Angeles, CA"},{"id":14307,"name":"Nextgen Media Ventures","slug":"nextgen-media-ventures","logoUrl":null,"website":"https://nextgennewmedia.com/","stageFocus":["Seed"],"sectorTags":["AI / ML","SaaS"],"hqGeo":"Los Angeles, CA"}],"featuredIn":[{"slug":"pre-seed","displayName":"Pre-Seed Investors","pageType":"stage"},{"slug":"saas","displayName":"SaaS Investors","pageType":"industry"},{"slug":"seed","displayName":"Seed Investors","pageType":"stage"},{"slug":"healthcare","displayName":"Healthcare Investors","pageType":"industry"}],"fundraisingResources":[{"slug":"how-vcs-help-portfolio-raise-follow-on","title":"How VCs Can Actually Help Their Portfolio Companies Raise Follow-On"},{"slug":"how-many-investors-should-you-pitch","title":"How Many Investors Should You Pitch? The Math Most Founders Get Wrong"},{"slug":"what-vcs-actually-look-for-pitch-deck","title":"What VCs Actually Look for in a Pitch Deck"}],"overviewNarrative":"BioGenerator Ventures is a venture capital firm headquartered in St. Louis, Missouri. The firm acts as a Midwest regional specialist that backs bioscience startups from formation through the seed stage. It maintains strong ties to translational science, life sciences tools, and early company building, and often invests in science-first companies before larger coastal firms engage.\n\nBioGenerator Ventures invests in the pre-seed and seed stages. Sectors include healthcare, life sciences, ag biotech, HR tech, and B2B SaaS. Typical check sizes range from $100K to $1.0M. Cold outreach is an accepted way to approach the firm.","portfolioNarrative":"BioGenerator Ventures has recorded investments in 18 portfolio companies. These include Arch Oncology in therapeutics, Benson Hill in agtech, Cadre Bioscience in research tools, Canopy Biosciences in research tools, Cardialen in medical devices, Confluence Life Sciences in biotech, CoverCress in agtech, Edison Agrosciences in agtech, Galera Therapeutics in therapeutics, Geneoscopy in diagnostics, Lymbus Oncology in therapeutics, MediBeacon in diagnostics, Omniose in therapeutics, Pairidex in biotech and diagnostics, and Peptyde Bio in biotech. Investments have been made at stages ranging from pre-seed and seed through Series B.\n\nThe firm continues to support Midwest bioscience companies across healthcare, life sciences, and agtech, with a focus on early-stage development in line with its regional investment thesis.","seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-06-28T22:10:10.768Z"}